2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Organ Donation and Allocation II

137.8 - Prolonged Cold Ischemia Time Before Double Kidney Transplantation Does Not Negatively Impact on Outcomes When Preserved by Pulsatile Machine Perfusion.

Presenter: Junichiro, Sageshima, Miami, United States
Authors: Fan J., Sageshima J., Ciancio G., Gaynor J., Sageshima J., Chen L., Grant D., Urahashi T., Brown R., Mattiazzi A., Guerra G., Kupin W., Roth D., Ganz S., Ruiz P., Burke, III G.

PROLONGED COLD ISCHEMIA TIME BEFORE DOUBLE KIDNEY TRANSPLANTATION DOES NOT NEGATIVELY IMPACT ON OUTCOMES WHEN PRESERVED BY PULSATILE MACHINE PERFUSION.

ORGAN DONATION AND ALLOCATION II

J. Fan1, J. Sageshima1, G. Ciancio1, J.J. Gaynor1, J. Sageshima1, L. Chen1, D.A. Grant2, T. Urahashi1, R. Brown1, A. Mattiazzi2, G. Guerra2, W. Kupin2, D. Roth2, S. Ganz2, P. Ruiz2, G.W. Burke, iii1
1Surgery, Kidney/pancreas Transplant, University of Miami Miller School of Medicine, Miami/UNITED STATES OF AMERICA, 2Miller School Of Medicine, University of Miami, Miami/UNITED STATES OF AMERICA

Body: Introduction: Double kidney transplantation from very marginal donors can increase the number of recipients who benefit from transplantation utilizing otherwise discarded kidneys. However, refusals by multiple transplant centers/recipients and more detailed assessments (e.g. pre-implantation histology) can prolong cold ischemia time (CIT).
Methods: To assess the impact of prolonged CIT, we retrospectively evaluated 72 consecutive recipients (Dec. 2004 to Dec. 2008) who received double kidney grafts that were deemed to be not suitable for single kidney transplantation. Two groups with long CIT (L-CIT: > 36 hr, n=24) and short CIT (S-CIT: ≤ 36 hr, n=48) were compared. All grafts were evaluated by histology and preserved on pulsatile machine perfusion (PP). T-cell depleting antibody induction and tacrolimus and mycophenolate (± steroids) based maintenance immunosuppressant were used.
Results: Overall, CIT was relatively long (median 33.0 hr [15.8 - 51.7 hr]); 63 patients (87.5%) had CIT > 24 hr and 5 patients (6.9%) had CIT > 48 hr. Baseline characteristics were similar with regard to donor age, history of hypertension, terminal creatinine, PP flow, PP resistance, and percent glomerulosclerosis. As expected, total CIT (pre-PP time + PP time) was longer in the L-CIT group than in the S-CIT group (43.2 ± 4.7 hr vs. 28.8 ± 5.0 hr, p < 0.0001); however, pre-PP (simple storage) time was similar (6.0 ± 2.5 hr vs. 5.7 ± 2.1 hr, p=0.658). The incidence of delayed graft function (requiring dialysis within 1 week post-transplant) was numerically (but not statistically) higher in the L-CIT group (4.2% vs. 2.1%, p=1.00), which did not lead to any adverse outcomes thereafter. Two-year death-censored graft survival was not different (L-CIT: 91.5% vs. S-CIT: 93.2%, p=0.696). Estimated GFR at 1 year post-transplant was similar (L-CIT: 68.7 ± 34.5 vs. S-CIT: 59.0 ± 27.0 mL/min/1.73 m2, p=0.235), and the percentage of patients with poor graft function (estimated GFR < 30 mL/min/1.73 m2) at 1 year was also similar (12.5% vs. 10.4%).
Conclusion: Despite prolonged CIT (up to 48 hours), double kidney transplantation can provide reasonable graft survival and renal graft function when preserved by PP. These grafts should not be discarded based on merely prolonged ischemia time.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada